These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3843616)

  • 1. Synthesis and evaluation of p-iodo-phentermine (IP) as a brain perfusion imaging agent.
    Kizuka H; Elmaleh DR; Brownell GL; Strauss HW; Hanson RN
    Nucl Med Commun; 1985 Jan; 6(1):49-56. PubMed ID: 3843616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biodistribution of labelled p-iodo phentermine (IP), N,N,-dimethyl-p-iodo phentermine (IDMP) and N-isopropyl-p-iodo phentermine (IIP) in rats.
    Moretti JL; Poncey MJ; Roux P; Desplanches J; Dao H; Lecayon M
    Nucl Med Commun; 1987 Jun; 8(6):441-7. PubMed ID: 3696629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of 3-[125I]iodo-4-aminophentermine as a brain perfusion imaging agent. Comparison with labeled phentermine derivatives.
    Hanson RN; Jones GS; Franke L; Kizuka H; Elmaleh DR
    Int J Nucl Med Biol; 1985; 12(4):321-5. PubMed ID: 4086198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain.
    Winchell HS; Horst WD; Braun L; Oldendorf WH; Hattner R; Parker H
    J Nucl Med; 1980 Oct; 21(10):947-52. PubMed ID: 6775056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-localization relationships of 11C-labeled phentermine derivatives: effect of aromatic substitution.
    Elmaleh DR; Kizuka H; Hanson RN; Jones GS; Herman LW; Strauss HW
    Appl Radiat Isot; 1993 May; 44(5):821-9. PubMed ID: 8485509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine.
    Kung HF; Tramposch KM; Blau M
    J Nucl Med; 1983 Jan; 24(1):66-72. PubMed ID: 6401325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of N-isopropyl-p-iodoamphetamine in the rat brain.
    Hoshi H; Jinnouchi S; Watanabe K; Ueda T; Kinoshita K; Yamaguchi T
    Nuklearmedizin; 1987 Jun; 26(3):131-4. PubMed ID: 3628020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of N-isopropyl-[125I]p-iodoamphetamine affinity sites in rat brain by autoradiography.
    Kondoh Y; Murakami M; Takahashi K; Itoh I; Mizusawa S; Nakamichi H; Sasaki H; Watanabe K; Tagawa K; Uemura K
    Tohoku J Exp Med; 1986 Jun; 149(2):229-30. PubMed ID: 2875546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals.
    Moretti JL; Holman BL; Delmon L; Carmel A; Johnson D; Moingeon P; Blau M
    J Nucl Med; 1987 Mar; 28(3):354-9. PubMed ID: 3029345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical and pharmacological aspects of cerebral cellular tracers].
    Rapin JR; Duterte D; Le Poncin-Lafitte M; Coornaert S; Desplanches G; Bardy A; Askienazy S; Moretti JL; Raynaud C
    Sem Hop; 1983 Dec; 59(48):3361-5. PubMed ID: 6318360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some factors affecting the cerebral and extracerebral accumulation of N-isopropyl-p-iodo-amphetamine (IAMP).
    Som P; Oster ZH; Yamamoto K; Meinken GE; Srivastava SC; Yonekura Y; Ebner SA; Atkins HL; Brill AB; Fawwaz RA
    Int J Nucl Med Biol; 1985; 12(3):185-96. PubMed ID: 3934094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vivo evaluation of 122I- and 131I-labelled iodoperidol, a potential agent for the tomographic assessment of cerebral perfusion.
    Moerlein SM; Mathis CA; Brennan KM; Budinger TF
    Int J Rad Appl Instrum B; 1987; 14(2):91-8. PubMed ID: 3484351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production.
    Holman BL; Wick MM; Kaplan ML; Hill TC; Lee RG; Wu JL; Lin TH
    J Nucl Med; 1984 Mar; 25(3):315-9. PubMed ID: 6699722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.
    Creutzig H; Schober O; Gielow P; Friedrich R; Becker H; Dietz H; Hundeshagen H
    J Nucl Med; 1986 Feb; 27(2):178-83. PubMed ID: 3486950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biodistribution of N-isopropyl-p-iodoamphetamine].
    Hoshi H; Jinnouchi S; Watanabe K; Ueda T; Yamaguchi T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Mar; 47(3):497-514. PubMed ID: 3615177
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism in vitro of radioiodinated N-isopropyl-p-iodoamphetamine by isolated hepatocytes.
    Moerlein SM; Weisman RA; Beck D; Li AP; Welch MJ
    Nucl Med Biol; 1993 Jan; 20(1):49-56. PubMed ID: 8461879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-isopropyl-p[123I]iodoamphetamine, a new agent for lung imaging studies.
    Van Zandwijk N; Zwijnenburg A; Hoefnagel CA; Marcuse HR
    Thorax; 1986 Oct; 41(10):801-3. PubMed ID: 3787512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method for the preparation of N-isopropyl-p-(123I)-iodoamphetamine with an assessment of radiochemical purity.
    Lyall D
    Nucl Med Commun; 1985 Aug; 6(8):485-8. PubMed ID: 4069473
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and biodistribution of 123I N-(2-aminoethyl)-5-iodo-2-pyridinecarboxamide (Ro 43-0463), a monoamine oxidase B inhibitor.
    Macwhorter SE; Baldwin RM
    Int J Rad Appl Instrum B; 1991; 18(5):563-4. PubMed ID: 1917527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography.
    Kuhl DE; Barrio JR; Huang SC; Selin C; Ackermann RF; Lear JL; Wu JL; Lin TH; Phelps ME
    J Nucl Med; 1982 Mar; 23(3):196-203. PubMed ID: 6801219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.